Dyax

 

Advancing Novel Biotherapeutics Since 1995®

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
8-K current report Jun 5, 2012 29.8 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Jun 1, 2012 31.7 KB View HTML View PDF View XLS Add to Briefcase
SC TO-I other May 21, 2012 1.5 MB View HTML View PDF View XLS Add to Briefcase
CT ORDER confidential treatment order May 14, 2012 7.1 KB View HTML View PDF Add to Briefcase
4 cohen, ron May 11, 2012 25.3 KB View HTML View PDF View XLS Add to Briefcase
4 mclachlan, david j May 11, 2012 32.1 KB View HTML View PDF View XLS Add to Briefcase
4 pucci, paolo May 11, 2012 25.3 KB View HTML View PDF View XLS Add to Briefcase
4 blair, henry e May 11, 2012 24.8 KB View HTML View PDF View XLS Add to Briefcase
8-K current report May 11, 2012 31.0 KB View HTML View PDF View XLS Add to Briefcase
4/A christensen gustav May 9, 2012 23.9 KB View HTML View PDF View XLS Add to Briefcase
4 christensen, gustav May 9, 2012 24.6 KB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report May 2, 2012 569.8 KB View HTML View PDF View XLS View XBRL Add to Briefcase
8-K current report Apr 24, 2012 58.1 KB View HTML View PDF View XLS Add to Briefcase
ARS annual report to security holders Apr 12, 2012 0.0 KB View HTML  
SC TO-C other Apr 11, 2012 24.8 KB View HTML View PDF View XLS Add to Briefcase
DEF 14A definitive proxy statement Apr 11, 2012 689.3 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Apr 3, 2012 24.0 KB View HTML View PDF View XLS Add to Briefcase
4 blair, henry e Mar 29, 2012 24.6 KB View HTML View PDF View XLS Add to Briefcase
PRE 14A preliminary proxy statement Mar 23, 2012 810.6 KB View HTML View PDF View XLS Add to Briefcase
4 christensen, gustav Mar 9, 2012 24.7 KB View HTML View PDF View XLS Add to Briefcase
Showing 141-160 of 653 Page: 1 ... 4 5 6 7 8 9 10 11 12 ... 33  Previous 20 | Next 20
Add to Briefcase = add PDF file to Briefcase
 

You are now leaving Dyax.com.

The web site you are about to visit is . It is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?